Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04084990 · ClinicalTrials.gov registry record · Phase 3
Sleep Apnea and Fetal Growth Restriction
A Phase 3 study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- Phase 3
- Development phase
- 3
- Enrollment target
NCT04084990: Clinical Trial Phase 3 study, sponsored by Washington University School of Medicine.
NCT04084990 is a Phase 3 study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 3 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04084990, a Phase 3 study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study aims to evaluate the association between obstructive sleep apnea (OSA) and fetal growth restriction (FGR) and to assess the role of auto-titrated positive airway pressure (aPAP) as antenatal therapy in these patients. Pregnant patients with diagnosed FGR will be screened for OSA first by screening questionnaire and then by home sleep monitor. Of those patients diagnosed with OSA, half will be assigned to use aPAP each night when sleeping and half will not (standard care).
Primary Outcome
Weight of child at time of birth
Interventions
- DEVICE S9 VPAP Adapt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2019-11-18 |
| Est. Completion | 2021-07-27 |
| Phase | Phase 3 |
Why NCT04084990 stopped before completion
NCT04084990 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which S9 VPAP Adapt is the first listed.
NCT04084990 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04084990 about?
NCT04084990 is a clinical study titled "Sleep Apnea and Fetal Growth Restriction". This study aims to evaluate the association between obstructive sleep apnea (OSA) and fetal growth restriction (FGR) and to assess the role of auto-titrated positive airway pressure (aPAP) as antenatal therapy in these patients. Pregnant patients with diagnosed FGR will be screened for OSA first by ...
What is the current status of trial NCT04084990?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 3 participants. The study started on 2019-11-18. Estimated completion is 2021-07-27.
What interventions are being tested in trial NCT04084990?
The interventions under investigation include: S9 VPAP Adapt (DEVICE).
Who is sponsoring clinical trial NCT04084990?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04084990's enrollment target sits among peer trials
3 1999th of 2000 higher than 1 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI